These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
195 related items for PubMed ID: 3489625
21. A pharmacological comparison of [3H]GBR12935 binding to rodent striatal and kidney homogenates: binding to dopamine transporters? Sharif NA, Nunes JL, Kalfayan V, McClelland DL, Rosenkranz RP, Eglen RM, Whiting RL. Neurochem Int; 1992 Jul; 21(1):69-73. PubMed ID: 1303143 [Abstract] [Full Text] [Related]
22. [3H]GBR-12935 binding sites in human striatal membranes: binding characteristics and changes in parkinsonians and schizophrenics. Hirai M, Kitamura N, Hashimoto T, Nakai T, Mita T, Shirakawa O, Yamadori T, Amano T, Noguchi-Kuno SA, Tanaka C. Jpn J Pharmacol; 1988 Jul; 47(3):237-43. PubMed ID: 3221529 [Abstract] [Full Text] [Related]
24. [3H]GBR-12935 binding to the dopamine transporter is decreased in the caudate nucleus in Parkinson's disease. Janowsky A, Vocci F, Berger P, Angel I, Zelnik N, Kleinman JE, Skolnick P, Paul SM. J Neurochem; 1987 Aug; 49(2):617-21. PubMed ID: 3598589 [Abstract] [Full Text] [Related]
25. Lack of increase in dopamine transporter binding or function in rat brain tissue after treatment with blockers of neuronal uptake of dopamine. Kula NS, Baldessarini RJ. Neuropharmacology; 1991 Jan; 30(1):89-92. PubMed ID: 2046881 [Abstract] [Full Text] [Related]
26. Interactions of amineptine with the neuronal dopamine uptake system: neurochemical in vitro and in vivo studies. Bonnet JJ, Chagraoui A, Protais P, Costentin J. J Neural Transm; 1987 Jan; 69(3-4):211-20. PubMed ID: 3625193 [Abstract] [Full Text] [Related]
27. Translocation of dopamine and binding of 2 beta-carbomethoxy-3 beta-(4-fluorophenyl) tropane (WIN 35,428) measured under identical conditions in rat striatal synaptosomal preparations. Inhibition by various blockers. Xu C, Coffey LL, Reith ME. Biochem Pharmacol; 1995 Jan 31; 49(3):339-50. PubMed ID: 7857321 [Abstract] [Full Text] [Related]
28. Comparison of [3H]WIN 35,428 binding, a marker for dopamine transporter, in embryonic mesencephalic neuronal cultures with striatal membranes of adult rats. Valchar M, Hanbauer I. J Neurochem; 1993 Feb 31; 60(2):469-76. PubMed ID: 8419533 [Abstract] [Full Text] [Related]
31. Specific binding of [3H]GBR 12783 to the dopamine neuronal carrier included in polarized membranes. Billaud G, Costentin J, Bonnet JJ. Eur J Pharmacol; 1993 Nov 15; 247(3):333-40. PubMed ID: 8307105 [Abstract] [Full Text] [Related]
32. In vivo binding of [3H]GBR 12783, a selective dopamine uptake inhibitor, in mouse striatum. Chagraoui A, Bonnet JJ, Protais P, Costentin J. Neurosci Lett; 1987 Jul 22; 78(2):175-9. PubMed ID: 3627558 [Abstract] [Full Text] [Related]
36. Dopamine high-affinity transport site topography in rat brain: major differences between dorsal and ventral striatum. Marshall JF, O'Dell SJ, Navarrete R, Rosenstein AJ. Neuroscience; 1990 Nov 03; 37(1):11-21. PubMed ID: 2243588 [Abstract] [Full Text] [Related]
38. Time course of postmortem modifications in synaptosomal [3H]dopamine uptake and [3H]GBR 12783 binding to the dopamine uptake complex in the rat striatum. Thibaut F, Bonnet JJ, Costentin J. Neurosci Lett; 1989 Jan 30; 96(3):335-9. PubMed ID: 2717059 [Abstract] [Full Text] [Related]
39. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding. Pristupa ZB, Wilson JM, Hoffman BJ, Kish SJ, Niznik HB. Mol Pharmacol; 1994 Jan 30; 45(1):125-35. PubMed ID: 8302271 [Abstract] [Full Text] [Related]